Sino IC Capital, a technology-focused PE fund manager backed by the Chinese government, has become the latest investor to fall foul of US regulators following the termination of its acquisition of semiconductor and electronics manufacturer Xcerra.
Unic Capital Management, an affiliate of Sino IC, agreed to buy Xcerra in April 2017 for around $580 million, using Hubei Xinyan Equity Investment Partnership. The deal won shareholder approval but failed...
The Asian Development Bank (ADB) has agreed to invest $25 million in Exacta Asia Investment II (Exacta II), a Southeast Asia-focused vehicle launched last year by Japan’s Mizuho Bank.
Bcause, a US-based cryptocurrency services company backed by SBI Holdings has received a commitment of undisclosed size from China Health Checkmate (CHC) to support an Asian expansion.
Wukongbao, a Beijing-based online insurance broker, has raised millions of US dollars in a Series B round led by Chinese classifieds platform 58.com, with participation from Guohua Life Insurance.
China Everbright has completed the first close of RMB800 million ($115.4 million) on its third healthcare fund. The overall target for the vehicle is around RMB1.5 billion.